Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-31 @ 12:39 AM
Study NCT ID:
NCT01501669
Status:
UNKNOWN
Last Update Posted:
2012-07-18
First Post:
2011-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Sponsor:
National Cancer Center, Korea
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-02
Completion Date Type:
ESTIMATED
First Submit Date:
2011-12-27
First Submit QC Date:
None
Study First Post Date:
2011-12-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-07-17
Last Update Post Date:
2012-07-18
Last Update Post Date Type:
ESTIMATED